Medication info
Teroben Tablets (Terbinafine Hydrochloride)

Teroben Tablets (Terbinafine Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets / bottle, 100 tablets / bottle
Approval status
Active

MFDS item code 201908449 · Approved 2019.12.16 · Insurance code 662504320

Summary

Main use
Treatment of onychomycosis and fungal skin infections (tinea pedis, tinea corporis, etc.) and tinea capitis
Who uses it
Adults · Children
Adult dosage
Adults Administer terbinafine 125 mg per dose twice daily or 250 mg per dose once daily. The treatment duration depends on the condition, as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. The treatment period may be shortened to 3 months or less for infections of the fingernails or relatively small toenails, or in younger patients. A treatment period of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. Patients with renal impairment For patients with creatinine clearance below 50 mL per minute, reduce the daily dose by 1/2.
Children's dosage
Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be administered regularly and appropriately for the prescribed duration. Body weight under 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Experience with administration is limited; the decision to administer should take into account the benefits and risks of treatment. Body weight 20~40 kg (5 years~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Treatment of onychomycosis and fungal skin infections (tinea pedis, tinea corporis, etc.) and tinea capitis

  • Tinea pedis
  • tinea corporis
  • tinea capitis
  • onychomycosis
View approved original text

This medication is used to treat various dermatophytoses caused by dermatophytes, such as tinea pedis, tinea corporis, and tinea capitis in adults. It is also used to treat tinea capitis in children.

Dosage and Administration

Adult dosage

Adults Administer terbinafine 125 mg per dose twice daily or 250 mg per dose once daily. The treatment duration depends on the condition, as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. The treatment period may be shortened to 3 months or less for infections of the fingernails or relatively small toenails, or in younger patients. A treatment period of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. Patients with renal impairment For patients with creatinine clearance below 50 mL per minute, reduce the daily dose by 1/2.

Children's dosage

Administer to children aged 2 years and older. Use is not recommended in children under 2 years of age because there is no experience with administration in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of infection, treatment should be administered regularly and appropriately for the prescribed duration. Body weight under 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Experience with administration is limited; the decision to administer should take into account the benefits and risks of treatment. Body weight 20~40 kg (5 years~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Precautions

This medication should not be used in patients with chronic liver disease or active liver disease. It is essential to check for any history of liver disease before using this medication. Liver function tests should be conducted before treatment and regularly monitored during treatment as liver function issues may arise. If liver function test results worsen, this medication should be discontinued immediately. If symptoms such as nausea, loss of appetite, fatigue, vomiting, upper right abdominal pain, jaundice, dark urine, or diarrhea occur while taking this medication, contact a doctor immediately. This medication can cause severe liver damage, such as liver failure, and should be discontinued if liver damage is suspected. Patients with allergies to this medication, blood disorders, severe renal failure, children under 2 years of age, and nursing mothers should not use this medication. Specifically, patients with lactose intolerance or certain genetic disorders should not take this medication. Caution is advised when using this medication in patients with reduced kidney function, elderly patients, and children weighing less than 20 kg. Rarely, severe skin reactions may occur, so if rashes or unusual symptoms develop, discontinue use immediately. This medication should only be used for treating fungal infections and should not be used if local treatment is possible. Dizziness and other symptoms may occur, so care should be taken when driving or operating machinery. Potential interactions may occur with other medications, so inform your doctor or pharmacist if you are currently taking any other medications. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication, and nursing mothers should discontinue breastfeeding while using it. Overdosage may lead to headache, nausea, upper abdominal pain, and dizziness, requiring immediate medical attention. This medication should be stored out of reach of children, away from direct sunlight, and at room temperature.

Side effects

Persistent nausea, appetite loss, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, loose stools, biliary tract failure, hepatitis, cholestasis, jaundice, rash, itching, fever, nausea, vomiting, anorexia, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photophobic reactions, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasiform rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasis, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, discomfort in the stomach, thirst, glossitis, depression, anxiety, headache, taste disorder, dizziness, drowsiness, sensory disturbances, sensory loss, decreased attention, insomnia, elevated BUN, frequent urination, visual disturbances, tinnitus, anaphylactic reactions, angioedema, systemic lupus erythematosus, elevated total cholesterol in the blood, elevated triglycerides, malaise, discoloration of the tongue, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reactions, serum sickness-like reactions, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, drug rash accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, flu-like illness, increased serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, ideally at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets / bottle, 100 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.